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The chemical fate of paroxetine metabolites.
Dehydration of radicals derived from 4-(4-
fluorophenyl)-3-(hydroxymethyl)piperidine†
Davor Šakić,a Florian Achrainer,b Valerije Vrček*a and Hendrik Zipseb
Quantum chemical calculations have been used to model reactions which are important for understand-
ing the chemical fate of paroxetine-derived radicals in the environment. In order to explain the experi-
mental observation that the loss of water occurs along the (photo)degradation pathway, four different
mechanisms of radical-induced dehydrations have been considered. The elimination of water from the N-
centered radical cation, which results in the formation of an imine intermediate, has been calculated as
the most feasible process. The predicted energy barrier (ΔG#298 = 98.5 kJ mol−1) is within the barrier limits
set by experimental measurements. All reaction intermediates and transition state structures have been
calculated using the G3(MP2)-RAD composite procedure, and solvent effects have been determined
using a mixed (cluster/continuum) solvation model. Several new products, which comply with the avail-
able experimental data, have been proposed. These structures could be relevant for the chemical fate of
antidepressant paroxetine, but also for biologically and environmentally related substrates.
Introduction
The antidepressant paroxetine (Paxil®) is an important represen-
tative of an emerging group of pharmacologically active phenyl-
piperidines. It is a selective serotonin reuptake inhibitor (SSRI)
that is widely prescribed to treat depression. Recent studies have
shown that paroxetine and its metabolites1–3 have the potential
to accumulate in waste waters,4 but also in the tissue of fish5 as
a result of discharges of this antidepressant into surface waters
from municipal wastewater treatment plants.6,7
Environmental risk assessment of paroxetine has been per-
formed earlier, but only the parent (3S,4R)-(4-(4′-fluorophenyl)-
3-(3,4-methylenedioxyphenoxymethyl)piperidine (I) and its
major human metabolite trans-4-[4-(4′-fluorophenyl)-3-piperi-
dinylmethoxy]-2-methoxyphenol (II) have been considered
(Scheme 1) in more detail.8 According to ecotoxicity results,
paroxetine itself should not exert any significant effects on
aquatic organisms. From an environmental fate perspective,
paroxetine appears to be hydrolytically stable, while irradiation
studies did not show any major UV degradants.
Kwon and Armbrust have shown that paroxetine, if
exposed to simulated sunlight, easily undergoes hydrolysis
and dehydration in the environment, resulting in relatively
stable by-product(s).9 The hydrolyzed photoproduct (3S,4R)-
4-(4-fluorophenyl)-3-(hydroxymethyl)piperidine (III) is con-
sidered as the main environmental metabolite, whereas the
possible dehydrated photoproduct has been designated as IV
(Scheme 1). It is likely that IV was produced by loss of water
followed by cyclization, but no mechanistic details have been
provided. The only structural information for the dehydrated
product is the mass spectrum signal at m/z 192 [M + H]+,
leading to a molecular mass of 191. No environmental risk
assessment has been performed for the two respective com-
pounds III and IV.
We have recently proposed that, along with the hydrolysis I →
III, a number of different rearrangements of paroxetine are
feasible if chlorination (HOCl/Cl2) of waste water is taken into
account.10 Chemical transformations of N-chlorinated deriva-
tive IIIa (Scheme 1) have been investigated computationally in
water as the reaction medium. In addition to the hydrolyzed
product III, alternative products have been predicted and
suggested as relevant for the chemical fate of paroxetine. In
order to provide a more comprehensive picture of reaction pos-
sibilities, the rearrangement reactions in the open-shell
counterparts of paroxetine metabolites are investigated in this
work. While the base-catalyzed reactions in the closed-shell
systems occur due to the water chlorination, the paroxetine-
derived radicals are generated through photolysis.
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Photodegradation of paroxetine follows first-order kinetics,
and the reaction rate constant at pH 7 is 0.0529 h−1.9 This
photodegradation process includes the hydrolysis of I to III
(the experimentally detected photoproduct), and the sub-
sequent rearrangement of III to the dehydration product (pre-
sumably IV). While the hydrolysis results in a single product
(III), different products may arise from dehydration of III
(Scheme 1). The experimentally-determined rate constant at
pH 7 (calculated as the rate of disappearance of I) corresponds
to an energy barrier of ca. 100 kJ mol−1 at 25 °C. The accuracy
of this value, which is based on the assumption of a unimole-
cular process, is not well established and we therefore assume
that all processes below or within a bracket of 10 kJ mol−1 of
the target experimental barrier (shown as a grey band in Fig. 1)
contribute to the measured reaction rate.
Based on the computational results presented here we
outline conceivable pathways for the formation of the (photo)
degradation products observed in the experimental studies of
Kwon and Armbrust. The computational results can also help
to identify the structures of photoproducts, which have been
proposed earlier on the basis of the MS signal only (m/z 192
[M + H]+). According to other experimental studies, hydrolysis
and dehydration of paroxetine can result in several products
with a molecular mass of 191.2,11–13 Therefore, in addition to
the photoproduct IV, additional structures V–XI (Scheme 1)
which match the observed MS signal should be considered as
possible degradation products of paroxetine.
In order to investigate all feasible pathways in radical-
mediated processes and to search for possible products,
quantum chemical models are used to calculate energies and
geometries of reaction intermediates and transition state struc-
tures. Of special importance is to clarify the mechanism of
dehydration which seems to be operative in photodegradation
of paroxetine derived radicals. Our investigation has been
focused on products which have chemical structures consistent
with the experimentally observed data. Only processes for which
the calculated energy barrier is lower than 200 kJ mol−1 have
been taken into account (see Fig. 1). It is important to note that
if any radical-mediated rearrangement corresponds to the rate-
determining step, it should not exceed the barrier limit of
ca. 100 kJ mol−1, as determined earlier in photolysis experiments.9
Four different pathways of dehydration have been con-
sidered computationally: (i) the formation of imines V and VI,
and enamine VII, (ii) the formation of alkenes VIII and IX,
(iii) cyclodehydration reactions resulting in aza-bicycloheptanes
X and XI, and (iv) the five-membered ring closure in IV. A more
comprehensive analysis and additional data for all reaction
possibilities are deposited in the ESI.† All investigated pro-
cesses include the dehydration step, which is in accord with
the experimental observation that the elimination of a water
molecule must occur along the degradation pathway.
A dehydration mechanism has been postulated in chemical
transformations of different phenylpiperidine-containing
biomolecules.14–17 Therefore, the comparative study of the
competitive processes i–iv is not only relevant for the chemical
fate of paroxetine, but may also be relevant for other biologi-
cally and environmentally relevant substrates.
Results and discussion
The photolytically induced homolysis9 of the N–H bond in the
(photo)product III or the N–Cl bond in the N-chlorinated
product IIIa can result in the formation of N-centered radical
1a (Scheme 2). It has been shown that N-chlorinated species
are more susceptible to photodegradation, mostly due to the
homolytic bond dissociation energy (BDE), which is lower for
the N–Cl bond than for the corresponding N–H bond.18 The
ease of formation of N-centered radicals has been reported for
a series of chloramines, which play an important role in
environmental chemistry and biochemistry.19–23
Once formed, the N-centered radical 1a can undergo fast
protonation yielding the radical cation 1b. The most stable
form of 1b adopts a chair conformation of the piperidine ring
Scheme 1 (Bio)degradation processes of paroxetine and its metabolites. Pro-
posed closed-shell products (C12H14FN) of rearrangements in paroxetine derived
radicals. Structures reported in earlier studies are designated by an asterisk.
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moiety with both substituents (fluorophenyl and hydroxy-
methyl) in the equatorial position (the conformer with substi-
tuents in the axial position is 11 kJ mol−1 less stable if
solvation effects are included). The spin density (NPA values) is
mainly localized on the nitrogen atom (0.73 au). The calcu-
lated pKa value for 1b (at the G3(MP2)-RAD + ΔGsolv level
according to the thermodynamic cycle presented in ESI†) is
6.5, which is similar to the parent piperidine radical (pKa =
5.8).24,25 This suggests that both neutral (1a) and protonated
(1b) forms coexist in neutral media. N-Centered radicals 1a
and 1b can undergo a variety of further rearrangements.26,27
It is known that protonation of aminyl radicals (such as 1a)
strongly affects the reactivity of these neutral
intermediates.28–31 Therefore, the radical cation 1b and its
rearranged products (see below) have been selected as species
relevant for the description of the chemical fate of paroxetine
metabolites. For comparison, rearrangements in the neutral
aminyl radical 1a have also been calculated and the corres-
ponding results have been deposited in the ESI.†
Dehydration of 1b with imine/enamine formation
It is known that N-centered radical cations may undergo frag-
mentation reactions, which involve the cleavage of the Cα–H
bonds.32 The homolytic cleavage is much easier than in the
neutral aminyl radical due to the strong electron withdrawing
effect of the positive charge in the protonated form.33,34
Therefore, N-centered radical cation 1b is expected to
undergo Cα–H cleavage in which a hydrogen atom is transferred
from either C2 or C6 to the C7-hydroxyl group (numbering
defined in Scheme 2). Both pathways were investigated computa-
tionally, with the former process being energetically more favor-
able. The calculated energy barrier ΔG# for the intramolecular
hydrogen atom transfer from the C2 position is 139.5 kJ mol−1
(kr = 8.10 × 10
−9 h−1). If one explicit water molecule is included
in the calculation, the energy barrier for 1b → 2 reduces to
98.5 kJ mol−1 (kr = 0.1235 h
−1), which is in line with the experi-
mentally determined limit for dehydration reaction (ca. 100
kJ mol−1 at 298.15 K). The corresponding transition state TS1b_2 is
characterized by a seven-membered ring geometry, in which the
water molecule assists C2–H cleavage coupled with (C7–O) bond
cleavage (Fig. 1). The latter bond is slightly elongated (1.49 Å) as
compared to 1b (1.41 Å) which suggests that the elimination of
water occurs simultaneously with the hydrogen atom transfer.
Only negligible spin density is located on the migrating hydro-
gen throughout the reaction (SD(Hmigr) = 0.01 in TS1b_2),
suggesting that spin flows directly from the nitrogen atom in 1b
(0.73 au) to the C7 carbon atom (1.04 au) in 2.
The iminium radical cation 2 and two water molecules have
been located at the product side of the reaction pathway using
the IRC procedure. This is a distonic radical in which the posi-
tive charge is distributed over the imine moiety (q(C2) = 0.39),
while the spin density is localized on the carbon center C7
(1.04 au). According to this result, the structure V (the closed-
shell analogue of 2) has been proposed as the dehydration
product of the metabolite III (or IIIa). It represents a conceiv-
able structure with chemical formula (in protonated form:
C12H15FN) which matches the experimentally observed signal
of m/z 192. The corresponding closed-shell analogue of
Fig. 1 Schematic energy profile (G3(MP2)-RAD + ΔGsolv) for dehydration mechanisms (the formation of imine/enamine (i), red lines; the alkene formation (ii),
magenta lines; the formation of azabicycloheptanes (iii), green lines; the five-membered ring closure (iv), blue lines) in radical cations 1b and 5 derived from the par-
oxetine metabolite III (or IIIa). Only the lower energy transition structures for water-assisted processes are presented. The energy of the N-centered radical 1b is set
to zero (dashed line). The gray band denotes the target experimental barrier for paroxetine (photo)degradation. Open-shell precursors (Arabic numerals) are con-
nected to their corresponding closed-shell products (Roman numerals).
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iminium radical cation 3 (structure VI in Scheme 1) is pre-
dicted to be only a minor product of the dehydration reaction.
The distonic radical cation 2 is more stable by 14.8 kJ mol−1
as compared to the N-centered radical 1b. It can undergo
further rearrangement through transfer of the C3–H atom to
the C7 position. While being forbidden by orbital symmetry
conservation rules (the calculated barrier ΔG# is over 220
kJ mol−1), this 1,2-hydrogen migration becomes feasible when
mediated by water molecules. The transition state structure
TS2_4 for the solvent assisted 1,2-hydrogen migration is calcu-
lated to be 91.7 kJ mol−1 above the imine 2, which makes this
rearrangement kinetically favorable. The resulting enamine
radical 4, presented in Scheme 2 with two resonance struc-
tures, has been calculated as the most stable rearranged
product (102.3 kJ mol−1 more stable than 1b). It is character-
ized by the planar C6–N1–C2–C3 moiety in which the spin is
distributed between N1 (0.40 au) and C3 (0.60 au) atoms. Its
closed-shell form corresponds to the structure VII in
Scheme 1.
Imines such as V and VI, and enamines such as VII may
easily undergo hydrolysis giving the expected products with
free amino and aldehyde functionalities.23,35,36 None of these
products, however, can be assigned to the observed signal in
the mass spectrum.37
Dehydration of 5 with alkene formation
The two alkene products VIII and IX (Scheme 1) have been
observed in elimination reactions of paroxetine meta-
bolites.12,38 The existence of VIII as an intermediate in the
degradation of III has also been confirmed by using electro-
spray ionization mass spectrometry (ESI-MS).11 In our quest
for the possible dehydration product, the alkenes VIII and IX
have been targeted as structures with chemical formula match-
ing the experimentally observed signal (m/z 192). The most
favorable pathway which precedes the formation of VIII and IX
corresponds to the loss of water from carbon-centered radical
cation 5. Radical cation 5 is a distonic form of the N-centered
radical 1b (charge and radical sites are spatially separated in 5),
Scheme 2 Proposed dehydration mechanisms (i–iv) in radical cations 1b and 5 derived from paroxetine metabolites III and IIIa. Closed-shell reactants/products
from Fig. 1 are indicated in boxes. Explicit water molecules coordinated to each radical cation are not presented.
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and is calculated to be 59.0 kJ mol−1 more stable than the
latter. The unpaired spin in 5 is localized on the C4 carbon
atom (0.74 au) with some flow to carbon centers C9 (0.22 au)
and C11 (0.21 au) in the phenyl ring. It is formed by the 1,4-
[N↔C]-hydrogen migration 1b → 5 via transition structure
TS1b_5. In this transition structure the water molecule is bound
to the migrating hydrogen (complex of type Hmigr⋯OH2 in
Fig. 1). Analysis of partial charge (NPA values) and spin distri-
bution along the 1,4-[N↔C]-H migration reveals that the
migrating hydrogen carries a positive charge throughout the
reaction (q(Hmigr) = 0.48 e in TS1b_5). Simultaneously, only the
negligible spin density is located on the Hmigr (0.02 au). The
calculated energy barrier for this intramolecular H-shift is
106.3 kJ mol−1 (kr = 5.33 × 10
−3 h−1), or 49.5 kJ mol−1 (kr =
0.4752 h−1) with one explicit water added to the system.
The transition state structure TS5_6 (Fig. 1), which connects
radical cation 5 and the alkene product 6, is located 206.0
kJ mol−1 (kr = 1.81 × 10
−20 h−1) above the starting radical cation
1b. Radical cation 6 can undergo further transformations to
yield the closed-shell alkenes VIII or IX, the latter of which is
more stable on thermochemical grounds.12 However, the cal-
culated energy barrier for 5 → 6 exceeds the experimentally
measured value of 100 kJ mol−1, which makes this dehydration
process kinetically less favorable.
Cyclodehydration reactions of 5
The elimination of water from radical cation 5 can also be
coupled to the formation of 3- or 4-membered ring systems. In
the cyclodehydration reaction 5 → 8 the simultaneous elimin-
ation of the C7-hydroxyl group and the hydrogen atom from
the N1 position results in the formation of the azabicyclo-
heptane product 8. The calculated energy barrier for this cyclopro-
panation reaction amounts to 161.2 kJ mol−1 (kr = 1.28 × 10
−11
h−1) if one explicit water is added, which is substantially lower
than the barrier for the formation of alkene radical cation 6
(see above). The radical cation product 8 can subsequently be
transformed into the closed-shell parent X, which has already
been targeted as a bioactive lead compound.39,40 It is closely
related to paroxetine as the azabicycloheptane derivatives have
been recently designed as potent and selective triple reuptake
inhibitors,41,42 and the same heterocyclic moiety has been
described as important in monoamine oxidase substrates.43
The cyclodehydration pathway 5 → 9 couples the elimin-
ation of water to the formation of an azetidine ring system
(Scheme 2). The dehydration reaction with azetidine ring
closure occurs in a number of pharmaceuticals based on
aminoalcohol substructures,44–46 including the tropane-
derived paroxetine analogs,47 which supports the proposal that
a similar mechanism can be expected in the paroxetine meta-
bolite III. The calculated energy barrier for 5 → 9 is 64.7
kJ mol−1 higher than the corresponding barrier for cyclodehydra-
tion 5 → 8. This is in line with earlier studies showing that the
energy barrier for azetidine ring formation in aminoalcohols48
or aminohalides49 can be quite substantial (up to 200
kJ mol−1).
Dehydration of 1b with five-membered ring formation
Cyclization reactions are also conceivable starting from radical
cation 2 and then involve formal radical attack at the aromatic
ring system to yield tricyclic radical cation 7. This is a distonic
radical in which the positive charge is distributed over the
imine moiety (q(C2) = 0.40 e), while the spin density is deloca-
lized over the carbon centers C8 (0.41 au), C10 (0.44 au) in the
phenyl ring. Radical addition reactions to aromatic ring
systems are generally considered to be thermochemically
unfavourable processes, but it should be added that intramole-
cular radical addition to a benzene ring system has recently
been reported for fibrate pharmaceuticals in the context of
environmental degradation processes.50 The calculated energy
barrier for the process 2 → 7 is 87.7 kJ mol−1 (kr = 9.72 h
−1),
which is within the barrier limits set by experimental measure-
ments. The respective transition state structure TS2_7 (Fig. 1) is
characterized by one imaginary frequency (544i cm−1), which
corresponds to the ring closure process. In this structure the
calculated distance between C7 and C9 carbon atoms is only
2.1 Å. The spin density distribution indicates that the spin is
considerably delocalized from the C7 carbon atom (0.63 au) to
carbon centers C8 (0.28 au), C9 (0.18 au), and C10 (0.27 au) in
the phenyl ring. The calculated energies of the ground states
suggest that the reaction 2 → 7 is slightly endergonic.
However, the reaction can proceed if the following energy
barrier for rearrangements of 7 is low and the final product is
lower in energy than reactant 2. In order to transform radical
cation 7 into the closed-shell product IV, the rearomatization
of the attacked ring systems and subsequent electron transfer
steps are required.
Conclusions
In this work we have compared the reaction energetics for
several dehydration processes which can occur in radical
cations generated by photolysis of the paroxetine metabolite
III (or IIIa). The barrier value of ca. 100 kJ mol−1 (at 298.15 K)
has been determined earlier by experimental measurements in
which paroxetine has been exposed to simulated sunlight and
kinetic parameters (kr = 0.0529 h
−1) of photodegradation have
been measured spectrophotometrically.9 It corresponds to the
estimated half-life of 13.1 h, indicating that the paroxetine
metabolite is not persistent to photolysis in water (pH = 7).
However, the photoproduct is stable under photolytic con-
ditions, and therefore a search for the mechanism of its for-
mation is of environmental relevance. All reaction possibilities,
for which the calculated barrier noticeably exceeds the limit set
by the experiment, are deposited in the ESI.†
Only the N-centered radical cation 1b and its distonic form
5 have been considered as important reactive intermediates.
The former is the free radical formed directly from the paroxe-
tine metabolite III (or IIIa), while the latter is the most stable
distonic isomer. Both species 1b and 5 are interconnected via
the structure TS1b_5 which represents the transition state for the
corresponding 1,4-hydrogen migration (ΔG# = 49.5 kJ mol−1;
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kr = 0.4752 h
−1). Two different rearrangements in the radical
cation 1b can be distinguished (Scheme 2): the elimination
of water resulting in imine 2 and enamine 4 formation
(i) and the cyclization of the initially formed imine giving
structure 7 (iv). As well, the radical cation 5 can undergo two
dehydration reactions: the elimination of water resulting in
the formation of alkene 6 (ii) and cyclodehydration in which
azabicycloheptanes 8 and 9 are formed (iii).
The elimination of water from the starting radical 1b has
been calculated as the most important reaction channel (ΔG# =
98.5 kJ mol−1; kr = 0.1235 h
−1) leading to the formation of
iminium radical cation 2. The latter species can be easily trans-
formed into enamine 4 (the most stable intermediate on the
potential energy surface investigated) or converted to 7 by an
intramolecular cyclization. The latter intermediate is an open-
shell precursor for the parent structure IV, which has been pro-
posed earlier as a possible photoproduct of the paroxetine
degradation in water.9 In contrast, the parent enamine VII,
derived from intermediate 4, has not been considered as a con-
ceivable product. We have shown here that, in both cases, the
imine radical 2 is the key intermediate for the formation of the
photoproducts IV and VII.
In addition, two cyclodehydration mechanisms (iii) have
been considered: the concerted one in which the cyclopropane
ring has been formed simultaneously with the elimination of
water, and the stepwise mechanism in which formation of the
four-membered azetidine moiety occurs after the elimination
of water. The calculated barriers for both reactions are rela-
tively high, with the former reaction 5 → 8 being the more
favorable process.
The dehydration process (ii), which results in the formation
of alkene radical 6, has been found to exceed the targeted
barrier limit of ca. 100 kJ mol−1. Although the formation of the
parent alkene products VIII and IX from paroxetine meta-
bolites has been detected experimentally,12,38 these reactions
most likely proceed without the intermediacy of free radicals.
The calculated barriers for all dehydration reactions start-
ing from structure 5, which occur prior to the formation of the
closed-shell parents VIII, IX, X and XI, are relatively high.
Therefore, these structures are unlikely candidates to explain
the experimental results. However, they could be important in
understanding the chemical fate of other environmentally rele-
vant compounds which are structurally related to paroxetine
(i.e. containing the phenyl-piperidine and/or aminoalcohol
groups). It is known that the dehydration process is important
for the metabolic and environmental fate of a series of phar-
maceuticals and other biologically relevant compounds, which
contain aminoalcohol moieties (R2N(CH2)nOH, where n = 2–4).
For example, haloperidol, the most widely used drug for the
treatment of neuropsychiatric disorders, undergoes dehy-
dration; it has been shown that dehydration is the first reac-
tion step in the bioactivation14 and electrochemical oxidation
of haloperidol.16 A similar dehydration mechanism has been
postulated in the transformation of selective inhibitors of
serine proteases15 and the central nervous system stimulant
pipradrol.17
In conclusion, quantum-chemistry models have been
employed in a search for products of radical-mediated photo-
degradation of paroxetine. Several structures, not considered
earlier, have been located, and the reaction mechanisms
underlying their formation have been described. We propose
structures IV, V, VI, and VII (Scheme 1) as probable photo-
products which fit to available experimental data.
Computational details
DFT calculations are employed for geometry optimizations and
frequency calculations for open-shell systems at the unrest-
ricted UB3LYP/6-31G(d) level.51 Thermal corrections to Gibbs
energies have been calculated at the same level of theory using
the rigid rotor/harmonic oscillator model. All energies are
reported at 298.15 K. Improved energetics have been calculated
using the double hybrid B2K-PLYP/6-311+G(3df,2p)52 and B2-
PLYP/aug-def2-TZVPP methods,53 which combine exact HF
exchange with an MP2-like correlation to a DFT calculation
(the corresponding energies are included in ESI†). It has been
found that B2K-PLYP shows an excellent performance for cal-
culating barrier heights for water-catalyzed proton-transfer
reactions,54 and radical reactions.55,56 The B2-PLYP method
has recently been successfully benchmarked against the G3B3
composite model.10 Finally, we use the G3(MP2)-RAD compo-
site model57 as our reference procedure in order to evaluate
the efficiency of DFT methods. Only the G3(MP2)-RAD energies
are reported throughout the text (calculated energies are rela-
tive to separated reactants). The (U)CCSD(T)/6-31G(d) calcu-
lations for the G3(MP2)-RAD model have been performed with
MOLPRO 2006.1,58 while all other quantum mechanical calcu-
lations have been performed with Gaussian 09.59
The calculated energy barriers (ΔG#, in kJ mol−1) are con-
verted to reaction rate constants (kr, in h
−1) throughout the
text. However, these estimates are rather approximate. A differ-
ence in Gibbs energy of activation of 5.7 kJ mol−1 (at 298.15 K)
results in a reaction rate difference of one order of magnitude.
Therefore, some caution must be exercised in the interpret-
ation of absolute values for the predicted reaction rate con-
stants, whereas the relative numbers are more reliable. The
corresponding half-life predictions are also sensitive to errors
in the calculation of ΔG#, which prevents an exact assessment
of the persistence of metabolites.
Analytical vibrational analysis was performed to character-
ize each stationary point as a minimum (number of imaginary
frequencies = 0) or a first-order saddle point (number of ima-
ginary frequencies = 1). Intrinsic reaction coordinate (IRC) cal-
culations were performed at the corresponding level of theory
to identify the minima connected through the transition state.
The initial geometries used were those of the corresponding
transition state structures, and the paths were followed in both
directions from that point. This method verified that a given
transition structure indeed connected the presumed energy
minimum structures.60
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Gibbs energies of solvation have been determined using the
CPCM continuum solvation model at the UB3LYP/6-31G(d)
level, with UAKS atomic radii and the electrostatic scaling
factor (alpha value) set to 1.2 for all atoms. The solvent relative
permittivity of ε = 78.4 (water) was used. To correctly describe
open-shell systems in water the inclusion of bulk and specific
solvent effects is mandatory. We have found that the addition
of one explicit water molecule substantially lowers the calcu-
lated energy barriers for all processes investigated. The
number of explicit water molecules (n = 0–3) is varied in order
to identify the most stable structure, i.e. to obtain the most
negative Gibbs energy of solvation. We have found that one
water molecule is “the ideal number of solvent molecules”61
for all structures involved in selected processes depicted in
Fig. 1 (see details in ESI†). The addition of the second and the
third water molecule is not favorable in Gibbs energy terms.
Therefore, all structures and relative energies reported
throughout the text include one extra water molecule. The
most stable forms of water-complexed species are located by
placing water molecules in a variety of locations to sample the
different arrays of interaction networks available between the
corresponding free radical and water. Initial configurations
were created using a locally modified version of the stochastic
search method.62–64
Different mechanisms for water-catalyzed reactions
(denoted as A, B, or C in ESI†) have been considered,65 but
only the most favorable are presented in the text (for selected
examples see Fig. 1).
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